SMS Pharmaceuticals Limited (NSE:SMSPHARMA)

SMS Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	37,807	18,863	15,089	4,931	7,915	10,518
Market Cap Growth	105.25%	25.01%	206.01%	-37.70%	-24.75%	361.90%
Enterprise Value	40,054	21,626	17,527	7,463	10,083	12,305
Last Close Price	403.70	212.49	177.81	57.96	92.73	122.98
PE Ratio	42.00	27.29	30.28	-	12.72	16.82
PS Ratio	4.21	2.41	2.13	0.95	1.52	1.87
PB Ratio	5.18	2.95	2.81	1.07	1.68	2.56
P/TBV Ratio	5.20	2.96	2.83	1.07	1.69	2.57
P/FCF Ratio	-	-	-	-	44.44	-
P/OCF Ratio	-	23.09	30.10	21.96	17.57	11.63
EV/Sales Ratio	4.46	2.76	2.47	1.43	1.94	2.19
EV/EBITDA Ratio	23.17	15.59	15.07	13.79	8.83	10.20
EV/EBIT Ratio	29.35	20.62	20.51	32.88	12.14	12.37
EV/FCF Ratio	-	-	-	-	56.61	-
Debt / Equity Ratio	0.45	0.49	0.52	0.55	0.56	0.62
Debt / EBITDA Ratio	1.90	2.23	2.40	4.64	2.29	2.09
Debt / FCF Ratio	-	-	-	-	14.78	-
Net Debt / Equity Ratio	0.31	0.42	0.46	0.54	0.46	0.52
Net Debt / EBITDA Ratio	1.32	1.94	2.10	4.56	1.90	1.77
Net Debt / FCF Ratio	-	-6.46	-120.21	-33.02	12.17	-3.49
Asset Turnover	-	0.72	0.74	0.60	0.62	0.79
Inventory Turnover	-	2.02	2.18	1.64	1.70	2.84
Quick Ratio	-	0.80	0.86	0.68	0.58	0.83
Current Ratio	-	1.71	1.61	1.61	1.92	1.58
Return on Equity (ROE)	-	11.76%	10.00%	-1.52%	14.13%	16.48%
Return on Assets (ROA)	-	6.00%	5.58%	1.63%	6.21%	8.76%
Return on Invested Capital (ROIC)	10.44%	9.12%	8.58%	3.26%	12.54%	11.98%
Return on Capital Employed (ROCE)	-	12.70%	12.20%	3.60%	12.50%	16.10%
Earnings Yield	2.37%	3.67%	3.30%	-1.43%	7.86%	5.95%
FCF Yield	-	-2.21%	-0.14%	-1.52%	2.25%	-5.83%
Dividend Yield	0.10%	0.19%	0.22%	0.52%	0.32%	0.24%
Payout Ratio	-	4.90%	5.10%	-	4.08%	-
Buyback Yield / Dilution	-10.24%	-4.72%	0.00%	-	-	-
Total Shareholder Return	-10.14%	-4.54%	0.22%	0.52%	0.32%	0.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.